Revolution Medicines (NASDAQ: RVMD)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-10 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.770 | -0.780 | -0.0100 | ||||
REV | 8.500M | 7.578M | -922.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Revolution Medicines (NASDAQ: RVMD) through any online brokerage.
Other companies in Revolution Medicines’s space includes: Valneva (NASDAQ:VALN), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Prothena Corp (NASDAQ:PRTA), Day One Biopharmaceutical (NASDAQ:DAWN) and Xencor (NASDAQ:XNCR).
The latest price target for Revolution Medicines (NASDAQ: RVMD) was reported by B of A Securities on Friday, May 20, 2022. The analyst firm set a price target for 24.00 expecting RVMD to rise to within 12 months (a possible 14.89% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Revolution Medicines (NASDAQ: RVMD) is $20.89 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Revolution Medicines.
Revolution Medicines’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for Revolution Medicines.
Revolution Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.